(Q45875009)
Statements
Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes (English)
Myriam Jean
Mohamad Alameh
Diogo De Jesus
Marc Thibault
Marc Lavertu
Monica Nelea
Abderrazzak Merzouki